Grant is an M.D./M.B.A. student at Harvard Medical School and Harvard Business School, a researcher at Boston Children’s Hospital, a board member of Project Alive, and the president and founder of ...

A team of scientists led by Duke-NUS Medical School has solved a mystery behind a rare and previously undiagnosed disease that affects multiple organs, shedding new light on its cause—and offering ...

But behind the viral videos is a serious diagnosis. Hannah has cystinosis, a rare metabolic disease that affects ...

In the five years since Italy-based Chiesi Group established its rare disease division in Boston, the unit has landed regulatory approvals worldwide for 10 therapies — all small molecules and ...

AT 19, Erin Corbett’s life changed in an instant — and the future she had imagined for herself suddenly looked very different ...

Gaucher disease is an underdiagnosed genetic disorder; early detection and treatment can prevent complications and ...

A research team in Lower Saxony is developing more accurate diagnostic methods for collagen diseases. “Zukunft.niedersachsen” is providing 2.7 million euros in funding.

MethylScan is a low-cost blood test that detects cancers and organ diseases by analyzing DNA methylation, improving early diagnosis, and identifying disease origin.

Key opportunities in the rare kidney diseases market include the significant growth potential driven by advancements in tailored therapies and precision treatments, a surge in funding and partnerships ...